The Latin America, Middle East and Africa Neuromonitoring Devices Market would witness market growth of 10.5% CAGR during the forecast period (2022-2028).
With the major goals of limiting morbidity and mortality associated with the original illness and preventing or lowering subsequent brain injury, neuromonitoring pre / post AIS is a cornerstone. Recent studies on noninvasive neuromonitoring have investigated the use of several modalities in severe brain injuries, including stroke, including transcranial ultrasound (TCU), evoked potentials (EP), electroencephalography (EEG), near-infrared spectroscopy (NIRS), and bispectral index (BIS).
The best-studied techniques include TCU, EEG, and somatosensory EP (SSEP), while BIS and NIRS are also intriguing modalities that need further research. Repeatability, adaptability, relatively low costs, and ease of execution and interpretation are benefits of noninvasive neuromonitoring. With the ultimate goal of synthesizing real-time data in a multimodal manner to enhance patient outcomes and further investigate pathophysiologic processes, noninvasive neuromonitoring will ideally be used to replace or supplement invasive techniques like probes or catheters.
The presence of multiple significant market participants is widespread in this area. These firms are significantly accelerating their attempts to introduce new inventions to the market to survive this fierce competition. Some of the main reasons propelling the internal neuromonitoring technologies market in Saudi Arabia, South Africa, and Turkey include growing rates and prevalence of neurological diseases, rapid population aging, development of enhanced neuromonitoring technologies, and higher awareness.
Companies developing and marketing internal neuromodulation implants have found success in emerging countries like Saudi Arabia, South Africa. The rise in neurological diseases and government initiatives to increase awareness through education campaigns are what is driving the need for internal neuromodulation technologies in these increasing market sectors.
The Brazil market dominated the LAMEA Neuromonitoring Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $140.6 million by 2028.The Argentina market is estimated to grow at a CAGR of 11.1% during (2022 - 2028). Additionally, The UAE market would witness a CAGR of 10.2% during (2022 - 2028).
Based on Product, the market is segmented into Doppler Ultrasound, EEG, Fetal/Neonatal Neuro-Monitoring Devices, Intracranial Pressure Monitoring, Cerebral Ox meter, Near Infrared Spectroscopy, Speckle Imaging, Micro Ultrasound, and Others. Based on End User, the market is segmented into Government, Energy, Defense, Agriculture & Forestry, Media & Entertainment, Civil Engineering & Archaeology, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Neuromonitoring Devices Market is Predict to reach $8.2 Billion by 2028, at a CAGR of 7.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Koninklijke Philips N.V., Medtronic PLC, Nihon Kohden Corporation, Natus Medical Incorporated, Nuvasive, Inc., Advanced Brain Monitoring, Inc., Intranerve Neuroscience Holdings, Llc, Specialtycare, and RIMED Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Product
- Doppler Ultrasound
- EEG
- Fetal/Neonatal Neuro-Monitoring Devices
- Intracranial Pressure Monitoring
- Cerebral Oximeter
- Near Infrared Spectroscopy
- Speckle Imaging
- Micro Ultrasound
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- General Electric (GE) Co. (GE Healthcare)
- Koninklijke Philips N.V.
- Medtronic PLC
- Nihon Kohden Corporation
- Natus Medical Incorporated
- Nuvasive, Inc.
- Advanced Brain Monitoring, Inc.
- Intranerve Neuroscience Holdings, Llc
- Specialtycare
- RIMED Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Neuromonitoring Devices Market, by Product
1.4.2 LAMEA Neuromonitoring Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Neuromonitoring Device Market
Chapter 4. LAMEA Neuromonitoring Devices Market by Product
4.1 LAMEA Doppler Ultrasound Market by Country
4.2 LAMEA EEG Market by Country
4.3 LAMEA Fetal/Neonatal Neuro-Monitoring Devices Market by Country
4.4 LAMEA Intracranial Pressure Monitoring Market by Country
4.5 LAMEA Cerebral Oximeter Market by Country
4.6 LAMEA Near Infrared Spectroscopy Market by Country
4.7 LAMEA Speckle Imaging Market by Country
4.8 LAMEA Micro Ultrasound Market by Country
4.9 LAMEA Others Market by Country
Chapter 5. LAMEA Neuromonitoring Devices Market by Country
5.1 Brazil Neuromonitoring Devices Market
5.1.1 Brazil Neuromonitoring Devices Market by Product
5.2 Argentina Neuromonitoring Devices Market
5.2.1 Argentina Neuromonitoring Devices Market by Product
5.3 UAE Neuromonitoring Devices Market
5.3.1 UAE Neuromonitoring Devices Market by Product
5.4 Saudi Arabia Neuromonitoring Devices Market
5.4.1 Saudi Arabia Neuromonitoring Devices Market by Product
5.5 South Africa Neuromonitoring Devices Market
5.5.1 South Africa Neuromonitoring Devices Market by Product
5.6 Nigeria Neuromonitoring Devices Market
5.6.1 Nigeria Neuromonitoring Devices Market by Product
5.7 Rest of LAMEA Neuromonitoring Devices Market
5.7.1 Rest of LAMEA Neuromonitoring Devices Market by Product
Chapter 6. Company Profiles
6.1 Medtronic PLC
6.1.1 Company overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expenses
6.1.5 Recent strategies and developments:
6.1.5.1 Approvals and Trials:
6.1.5.2 Acquisition and Mergers:
6.2 NuVasive, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Partnerships, Collaborations, and Agreements:
6.2.5.2 Approvals and Trials:
6.3 General Electric (GE) Co. (GE Healthcare)
6.3.1 Company Overview
6.3.2 Segmental and Regional Analysis
6.3.3 Research & Development Expense
6.3.4 Recent strategies and developments:
6.3.4.1 Partnerships, Collaborations, and Agreements:
6.3.5 SWOT Analysis
6.4 Natus Medical Incorporated
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional & Segmental Analysis
6.4.4 Research & Development Expenses
6.5 Koninklijke Philips N.V.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.5.5 Recent strategies and developments:
6.5.5.1 Acquisition and Mergers:
6.6 SpecialtyCare
6.6.1 Company Overview
6.6.2 Recent strategies and developments:
6.6.2.1 Acquisition and Mergers:
6.7 Nihon Kohden Corporation
6.7.1 Company Overview
6.8 Advanced Brain Monitoring, Inc.
6.8.1 Company Overview
6.9 IntraNerve Neuroscience Holdings, LLC
6.9.1 Company Overview
6.10. Rimed Ltd.
6.10.1 Company Overview
TABLE 1 LAMEA Neuromonitoring Devices Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Neuromonitoring Devices Market, 2022 - 2028, USD Million
TABLE 3 LAMEA Neuromonitoring Devices Market by Product, 2018 - 2021, USD Million
TABLE 4 LAMEA Neuromonitoring Devices Market by Product, 2022 - 2028, USD Million
TABLE 5 LAMEA Doppler Ultrasound Market by Country, 2018 - 2021, USD Million
TABLE 6 LAMEA Doppler Ultrasound Market by Country, 2022 - 2028, USD Million
TABLE 7 LAMEA EEG Market by Country, 2018 - 2021, USD Million
TABLE 8 LAMEA EEG Market by Country, 2022 - 2028, USD Million
TABLE 9 LAMEA Fetal/Neonatal Neuro-Monitoring Devices Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA Fetal/Neonatal Neuro-Monitoring Devices Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA Intracranial Pressure Monitoring Market by Country, 2018 - 2021, USD Million
TABLE 12 LAMEA Intracranial Pressure Monitoring Market by Country, 2022 - 2028, USD Million
TABLE 13 LAMEA Cerebral Oximeter Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA Cerebral Oximeter Market by Country, 2022 - 2028, USD Million
TABLE 15 LAMEA Near Infrared Spectroscopy Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA Near Infrared Spectroscopy Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Speckle Imaging Market by Country, 2018 - 2021, USD Million
TABLE 18 LAMEA Speckle Imaging Market by Country, 2022 - 2028, USD Million
TABLE 19 LAMEA Micro Ultrasound Market by Country, 2018 - 2021, USD Million
TABLE 20 LAMEA Micro Ultrasound Market by Country, 2022 - 2028, USD Million
TABLE 21 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 22 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 23 LAMEA Neuromonitoring Devices Market by Country, 2018 - 2021, USD Million
TABLE 24 LAMEA Neuromonitoring Devices Market by Country, 2022 - 2028, USD Million
TABLE 25 Brazil Neuromonitoring Devices Market, 2018 - 2021, USD Million
TABLE 26 Brazil Neuromonitoring Devices Market, 2022 - 2028, USD Million
TABLE 27 Brazil Neuromonitoring Devices Market by Product, 2018 - 2021, USD Million
TABLE 28 Brazil Neuromonitoring Devices Market by Product, 2022 - 2028, USD Million
TABLE 29 Argentina Neuromonitoring Devices Market, 2018 - 2021, USD Million
TABLE 30 Argentina Neuromonitoring Devices Market, 2022 - 2028, USD Million
TABLE 31 Argentina Neuromonitoring Devices Market by Product, 2018 - 2021, USD Million
TABLE 32 Argentina Neuromonitoring Devices Market by Product, 2022 - 2028, USD Million
TABLE 33 UAE Neuromonitoring Devices Market, 2018 - 2021, USD Million
TABLE 34 UAE Neuromonitoring Devices Market, 2022 - 2028, USD Million
TABLE 35 UAE Neuromonitoring Devices Market by Product, 2018 - 2021, USD Million
TABLE 36 UAE Neuromonitoring Devices Market by Product, 2022 - 2028, USD Million
TABLE 37 Saudi Arabia Neuromonitoring Devices Market, 2018 - 2021, USD Million
TABLE 38 Saudi Arabia Neuromonitoring Devices Market, 2022 - 2028, USD Million
TABLE 39 Saudi Arabia Neuromonitoring Devices Market by Product, 2018 - 2021, USD Million
TABLE 40 Saudi Arabia Neuromonitoring Devices Market by Product, 2022 - 2028, USD Million
TABLE 41 South Africa Neuromonitoring Devices Market, 2018 - 2021, USD Million
TABLE 42 South Africa Neuromonitoring Devices Market, 2022 - 2028, USD Million
TABLE 43 South Africa Neuromonitoring Devices Market by Product, 2018 - 2021, USD Million
TABLE 44 South Africa Neuromonitoring Devices Market by Product, 2022 - 2028, USD Million
TABLE 45 Nigeria Neuromonitoring Devices Market, 2018 - 2021, USD Million
TABLE 46 Nigeria Neuromonitoring Devices Market, 2022 - 2028, USD Million
TABLE 47 Nigeria Neuromonitoring Devices Market by Product, 2018 - 2021, USD Million
TABLE 48 Nigeria Neuromonitoring Devices Market by Product, 2022 - 2028, USD Million
TABLE 49 Rest of LAMEA Neuromonitoring Devices Market, 2018 - 2021, USD Million
TABLE 50 Rest of LAMEA Neuromonitoring Devices Market, 2022 - 2028, USD Million
TABLE 51 Rest of LAMEA Neuromonitoring Devices Market by Product, 2018 - 2021, USD Million
TABLE 52 Rest of LAMEA Neuromonitoring Devices Market by Product, 2022 - 2028, USD Million
TABLE 53 Key Information – Medtronic PLC
TABLE 54 Key Information – NuVasive, Inc.
TABLE 55 Key Information – General Electric (GE) Co.
TABLE 56 Key Information – Natus Medical Incorporated
TABLE 57 Key Information – Koninklijke Philips N.V.
TABLE 58 Key Information – SpecialtyCare
TABLE 59 key Information – Nihon Kohden Corporation
TABLE 60 Key Information – Advanced Brain Monitoring, Inc.
TABLE 61 Key Information – IntraNerve Neuroscience Holdings, LLC
TABLE 62 Key Information – Rimed Ltd.
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Medtronic Plc
FIG 3 Recent strategies and developments: Nuvasive, Inc.
FIG 4 Swot analysis: General electric (GE) Co.